Orchard Therapeutics Company
Autologous gene therapies for a range of serious disorders
Investors
.png)
.png)
(Reupload).png)
.jpg)
.png)
(Reupload).png)
.png)
(Reupload).png)
Technology:
Others
Industry:
Cell Therapy
Headquarters:
London, England, United Kingdom
Founded Date:
2015
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
24
Total Funding:
$310.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership